Latest News in the pharma Industry
Research & Development
New Biogen Hemophilia Data At ISTH Congress to Highlight Extension Study Outcomes and Pediatric Use
18 Jun 2015
Read more
Novartis Presents New Data from Large European Study Reinforcing the Benefit of First-Line Tasigna in Newly-Diagnosed Patients with CML
17 Jun 2015
Read more
Eli Lilly Enters Into Strategic Partnership with Sarah Cannon Research Institute to Develop Investigational Oncology Therapy
17 Jun 2015
Read more
Novartis Drug Arzerra Improved Median Progression-Free Survival by 54% in Patients with Relapsed Chronic Lymphocytic Leukemia
15 Jun 2015
Read more
Bial to Present Data on Opicapone at the 19th International Congress of Parkinson's Disease and Movement Disorders
12 Jun 2015
Read more
Pfizer Reports Top Line Results from a Phase III Study Evaluating Desvenlafaxine Succinate Sustained-Release Formulation
12 Jun 2015
Read more
BMS Demonstrates Commitment to Hematology and Advancing R&D Across Multiple Blood Cancers Through Immuno-Oncology Leadership
11 Jun 2015
Read more
LDC to Collaborate with Johnson & Johnson Innovation on Acceleration of Academic Drug Discovery Initiatives
11 Jun 2015
Read more
TECOS, Merck’s Cardiovascular Safety Trial of Januvia (Sitagliptin), Met Primary Endpoint in Patients with Type 2 Diabetes
9 Jun 2015
Read more
Lilly's Basal Insulin Peglispro Shows Superiority to Insulin Glargine in Reducing HbA1c in People with Type 2 Diabetes
8 Jun 2015
Read more